Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACTINOMYCIN vs DAPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACTINOMYCIN vs DAPAGLIFLOZIN: Safety Overview

Metric DACTINOMYCIN DAPAGLIFLOZIN
Total FAERS Reports 2,858 21,367
Deaths Reported 507 3,633
Death Rate 17.7% 17.0%
Hospitalizations 721 8,467
Average Patient Age 18.8 yrs 64.9 yrs
% Female Patients 65.9% 44.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Jan 8, 2014
Manufacturer Eugia US LLC AstraZeneca Pharmaceuticals LP
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription